Insiders · Profile

Gayer Charles K

Chief Commercial Officer at BIOCRYST PHARMACEUTICALS. Filing since 15 Dec 2022. CIK 0001800110

Company

Date

Role

Action

Amount

Of holding

13 May 2024

Chief Commercial Officer

Bought

30,000

$164.10K

10.8%

15 Dec 2022

Chief Commercial Officer

Sold, plan not stated

6,100

$66.49K

2.8%

2 decisions on file.